Cancer testis antigens: A new paradigm for cancer therapy

OncoImmunology

Volumn 1, Issue 7, 2012, Pages 1194-1196

  Suri, Anil ^a   Saini, Shikha ^a   Sinha, Abhilasha ^a   Agarwal, Sumit ^a   Verma, Archana ^a   Parashar, Deepak ^a   Singh, Swarnendra ^a   Gupta, Namita ^a   Jagadish, Nirmala ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Biomarkers; Cancer testis antigens; Cancer vaccines; Immunotherapy; SPAG9

Indexed keywords

CANCER TESTIS ANTIGEN; CANCER VACCINE; IPILIMUMAB; METRONIDAZOLE; NY ESO 1 ANTIGEN; RILIMOGENE GALVACIREPVEC;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; KIDNEY CARCINOMA; MELANOMA; NEOPLASM; NONHUMAN; OVARY CANCER; OVARY CARCINOMA; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; TUMOR CELL; UTERINE CERVIX CANCER;

EID: 84872648991     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.20686     Document Type: Article

References (10)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2012; 62:10-29; PMID:22237781; http://dx.doi.org/10.3322/caac.20138.
2. Suri A. Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther 2006; 6:379-89; PMID:16548764; http://dx.doi.org/10.1517/14712598.6.4.379.
3. Scudellari M. A ballsy search for cancer targets. Nat Med 2011; 17:916-8; PMID:21818078; http://dx.doi.org/10.1038/nm0811-916.
4. Jagadish N, Rana R, Selvi R, Mishra D, Garg M, Yadav S, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homol-ogy with c-Jun N-terminal kinase-interacting protein. Biochem J 2005; 389:73-82; PMID:15693750; http://dx.doi.org/10.1042/BJ20041577.
5. Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, et al. Sperm associated antigen 9 is associated with tumor growth, migration and invasion in renal cell carcinoma. Cancer Res 2008; 68:8240-48; PMID:18922895; http://dx.doi.org/10.1158/0008-5472.CAN-08-1708
6. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm associated antigen 9 (SPAG9), a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:630-9; PMID:19190149.
7. Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol 2011; 178:1009-20; PMID:21356354; http://dx.doi.org/10.1016/j.ajpath.2010.11.047.
8. Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, et al. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci USA 2012; 109:5797-802; PMID:22454499; http://dx.doi.org/10.1073/pnas.1117208109.
9. Mohebtash M, Tsang KY, Madan RA, Huen NY, Poole DJ, Jochems C, et al. A pilot study of MUC-1/CEA/ TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer. Clin Cancer Res 2011; 17:7164-73; PMID:22068656; http://dx.doi.org/10.1158/1078-0432.CCR-11-0649.
10. Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, et al. Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. Lancet Oncol 2012; 13:501-8; PMID:22326924; http://dx.doi.org/10.1016/S1470-2045(12)70006-2.